Next Article in Journal
Methods To Identify Aptamers against Cell Surface Biomarkers
Next Article in Special Issue
Target Profile Prediction and Practical Evaluation of a Biginelli-Type Dihydropyrimidine Compound Library
Previous Article in Journal
Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and Neurodegeneration
Previous Article in Special Issue
Prediction of Positions of Active Compounds Makes It Possible To Increase Activity in Fragment-Based Drug Development
Pharmaceuticals 2011, 4(9), 1196-1215; doi:10.3390/ph4091196
Review

In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions

1
, 2
, 2
, 1
, 2
, 1
, 3
, 2
 and 1,*
Received: 5 August 2011; in revised form: 23 August 2011 / Accepted: 29 August 2011 / Published: 1 September 2011
(This article belongs to the Special Issue Advances in Drug Design)
View Full-Text   |   Download PDF [2144 KB, uploaded 2 September 2011]   |   Browse Figures
Abstract: Recently the first community-wide assessments of the prediction of the structures of complexes between proteins and small molecule ligands have been reported in the so-called GPCR Dock 2008 and 2010 assessments. In the current review we discuss the different steps along the protein-ligand modeling workflow by critically analyzing the modeling strategies we used to predict the structures of protein-ligand complexes we submitted to the recent GPCR Dock 2010 challenge. These representative test cases, focusing on the pharmaceutically relevant G Protein-Coupled Receptors, are used to demonstrate the strengths and challenges of the different modeling methods. Our analysis indicates that the proper performance of the sequence alignment, introduction of structural adjustments guided by experimental data, and the usage of experimental data to identify protein-ligand interactions are critical steps in the protein-ligand modeling protocol.
Keywords: comparative modeling; ligand binding mode prediction; G protein-coupled receptor (GPCR); GPCR Dock 2010 comparative modeling; ligand binding mode prediction; G protein-coupled receptor (GPCR); GPCR Dock 2010
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Roumen, L.; Sanders, M.P.; Vroling, B.; De Esch, I.J.; De Vlieg, J.; Leurs, R.; Klomp, J.P.; Nabuurs, S.B.; De Graaf, C. In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions. Pharmaceuticals 2011, 4, 1196-1215.

AMA Style

Roumen L, Sanders MP, Vroling B, De Esch IJ, De Vlieg J, Leurs R, Klomp JP, Nabuurs SB, De Graaf C. In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions. Pharmaceuticals. 2011; 4(9):1196-1215.

Chicago/Turabian Style

Roumen, Luc; Sanders, Marijn P.A.; Vroling, Bas; De Esch, Iwan J.P.; De Vlieg, Jacob; Leurs, Rob; Klomp, Jan P.G.; Nabuurs, Sander B.; De Graaf, Chris. 2011. "In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions." Pharmaceuticals 4, no. 9: 1196-1215.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert